Generic Name and Formulations:
Hexachlorophene 3%; emulsion.
Indications for PHISOHEX:
Surgical scrub and bacteriostatic skin cleanser.
Infants: not recommended. Others: see literature.
Burns. Denuded skin. Do not use as an occlusive dressing, wet pack or lotion or on mucous membranes. Do not get into eyes. Routine prophylactic total body bathing. Generalized dermatological conditions.
Rinse thoroughly after use (esp. scrotum and perineum). If cerebral irritability occurs, discontinue use immediately. Infants and young children. Pregnancy (Cat. C). Nursing mothers: not recommended.
Dermatitis, irritability, photosensitivity, redness, mild scaling and dryness of skin. Severe toxic reactions (brain damage and death) via skin absorption in infants and young children.
Emulsion—5 oz, pt, gal
Sign Up for Free e-newsletters
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|